PLYMOUTH – Partner with Bank of America Merrill Lynch on Jan. 28 and meet one-on-one with Michio’s BioConnections investment partners at the Michigan Life Sciences Innovation Center. But you need to submit your executive summary by Jan. 22 to participate. 

Bank of America Merrill Lynch (BofAML) is one of the world’s leading financial institutions, serving small and middle-market businesses and large corporations with a full range of investing, asset management, banking and other financial and risk management products and services.

The Healthcare Investment Banking group at BofAML has unparalleled and diverse sector expertise in select equity offering transactions (IPOs), strategic advisory transactions, and leveraged finance transactions. From concept to completion, BofAML is able to provide trustworthy strategic M&A advice, capital markets expertise and a range of financial solutions that can help a business achieve its goals. Also, it can make connections to capital raising expertise across the debt and equity markets that can be used to expand and improve a company.

BofAML-Healthcare Investment Banking is interested in meeting bioscience companies at all stages of business life cycle – emerging (e.g., seed, early- and late- stage), mid-market and established revenue – and across the full spectrum of healthcare (medical devices and technologies, biopharma, diagnostics and personalized medicine, digital health and telemedicine, etc.) and agri-biosciences (food/nutrition, bio-based technologies, renewable bio-based products, bioenergy).

APPLICATION QUALIFICATIONS & INSTRUCTIONS